AIDS Vaccine Week articles from May 2009

AIDS Vaccine Week archives from May 2009

Newly published study shows that re-treatment with Pegasys[R] (peginterferon alfa-2a) provides hepatitis C patients with a second chance for a cure.(Clinical report)
May 4, 2009... New data published in Annals of Internal Medicine show that re-treatment with Pegasys® (peginterferon alfa-2a) plus Copegus® (ribavirin) provides previously-treated hepatitis C patients a second chance for a cure. The study...

Reports from Baylor College of Medicine, College of Medicine describe recent advances in cancer vaccines.
May 4, 2009... According to a study from the United States, "Squamous cell carcinoma of the anus (SCCA) is a rare disease in the average population but is an increasing concern among immunocompromised individuals, such as the HIV-seropositive. Coinfection...

Recent findings in HIV/AIDS described by Y. Kawashima and colleagues.
May 4, 2009... According to recent research from Oxford, the United Kingdom, "The rapid and extensive spread of the human immunodeficiency virus (HIV) epidemic provides a rare opportunity to witness host-pathogen co-evolution involving humans. A focal point...

Research from A. Jaworowski and colleagues provide new insights into HIV/AIDS.
May 4, 2009... "Human immunodeficiency virus type 1 (HIV-1) coinfection decreases antibodies to variant surface antigens implicated in pregnancy-associated malaria (VSA-PAM) caused by Plasmodium falciparum. The effect of HIV-1 on antibody functions that may...

Researchers at University of Cape Town target HIV/AIDS.
May 4, 2009... According to a study from Cape Town, South Africa, "The high diversity of HIV variants driving the global AIDS epidemic has caused many to doubt whether an effective vaccine against the virus is possible. However, by identifying the selective...

New life sciences study findings have been reported by S. Swartzentruber and co-researchers.
May 4, 2009... "The sensitivity for detection of Histoplasma antigen is lower in serum than in urine. In other antigen assays, treatment of serum at 104 degrees C in the presence of EDTA was required for detection of antigenemia," researchers in the United...

Nobel Laureate Celebrates With Thomson Reuters, Drs. Clotet and Gatell Ten Years of HIV Updates.
May 4, 2009... The Healthcare and Science business of Thomson Reuters and Drs. Clotet and Gatell have invited Francoise Barre-Sinoussi, winner of the 2008 Nobel Prize in Medicine, to give a keynote speech to celebrate the 10th anniversary of Prous Science -...

Report summarizes adenovirus study findings from National Institutes of Health.
May 11, 2009... According to recent research from the United States, "Previously, chronic-phase protection against SHIV89.6P challenge was significantly greater in macaques primed with replicating adenovirus type 5 host range mutant (Ad5hr) recombinants...

New antiretrovirals findings from New York University published.
May 11, 2009... "Although retroviruses have been extensively studied for many years, basic questions about how retroviral infections are detected by the immune system and which innate pathways are required for the generation of immune responses remain...

Research from Emory University, Emory Vaccine Center provides new data on hepatitis C virus.
May 11, 2009... According to a study from the United States, "Adaptive T cell responses are critical for controlling infections with viruses such as HIV, HBV, and HCV. However, these responses must be carefully regulated because overly vigorous T cell...

New findings from American University in the area of HIV/AIDS described.
May 11, 2009... "First generation HIV vaccines may have limited ability to prevent infection. Instead, they may delay the onset of AIDS or reduce the infectiousness of vaccinated individuals who become infected," scientists in the United States report (see...

Recent findings in HIV/AIDS described by P. Ravanfar and colleagues.
May 11, 2009... According to a study from the United States, "Human immunodeficiency virus (HIV) infection is a worldwide epidemic, with over 42 million people currently infected." "Since the discovery of HIV as the causative agent of the acquired immune...

Research from Novartis broadens understanding of HIV/AIDS.
May 11, 2009... According to recent research from the United States, "Human immunodeficiency virus type 1 (HIV-1) entry into host cells is mediated by the trimeric envelope glycoprotein complex (Env). Accordingly, the Env proteins are the targets for...

Research on HIV/AIDS reported by scientists at Massachusetts General Hospital.
May 11, 2009... According to recent research published in the Journal of Virology, "Defining the antiviral efficacy of CD8 T cells is important for immunogen design, and yet most current assays do not measure the ability of responses to neutralize infectious...

Studies from University of Toronto in the area of HIV/AIDS published.(Report)
May 11, 2009... "Existing knowledge and beliefs related to HIV vaccines provide an important basis for the development of risk communication messages to support future HIV vaccine dissemination. This study explored HIV vaccine mental models among adults from...

University of Lausanne reports research in HIV/AIDS co-infection.(Report)
May 11, 2009... "Cytotoxic CD8 T cells exert their antiviral and antitumor activity primarily through the secretion of cytotoxic granules. Degranulation activity and cytotoxic granules ( perforin plus granzymes) generally define CD8 T cells with cytotoxic...

Study results from Harvard University, Medical Department in the area of life sciences published.
May 11, 2009... "Strains of simian immunodeficiency virus (SIV) that are limited to a single cycle of infection were evaluated for the ability to elicit protective immunity against wild-type SIV(mac)239 infection of rhesus macaques by two different vaccine...

Rwanda Becomes First Developing Nation to Introduce Vaccine for World's Leading Infectious Child Killer.
May 11, 2009... International leaders in global health will join Rwandan government officials at a press conference in the coming days in Kigali to announce the first national immunisation programme against pneumococcal disease in a developing country....

CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease.(Conference news)
May 11, 2009... CEL-SCI Corporation (NYSE Amex: CVM) announced the presentation of data at the 11th annual National Foundation of Infectious Diseases Conference in Baltimore which demonstrates how vaccines utilizing its L.E.A.P.S.(TM) (Ligand Epitope Antigen...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference.(Conference news)
May 11, 2009... Global progress toward a malaria vaccine is among the key topics to be presented at the 12th Annual Conference on Vaccine Research (ACVR), sponsored by the National Foundation for Infectious Diseases (NFID) April 27-29, 2009 in Baltimore. The...

Study data from University of Minnesota update knowledge of anti-infectives.
May 18, 2009... According to a study from the United States, "Although there has been great progress in treating human immunodeficiency virus 1 (HIV-1) infection(1), preventing transmission has thus far proven an elusive goal. Indeed, recent trials of a...

Investigators at Duke University publish new data on HIV/AIDS.
May 18, 2009... According to recent research published in the Journal of Virology, "The broadly neutralizing human monoclonal antibodies (MAbs) 2F5 and 4E10, both targeting the highly conserved human immunodeficiency virus type 1 (HIV-1) envelope membrane...

Research on HIV/AIDS detailed by scientists at University of Oxford.
May 18, 2009... According to recent research from Compton, the United Kingdom, "Characterization of the immune responses induced in the initial stages of human immunodeficiency virus type 1 (HIV-1) infection is of critical importance for an understanding of...

Viroblock SA Reports a 99% Boost of Efficacy of Facemasks Against H5N1.
May 18, 2009... Viroblock SA announces that its antiviral products boosts the efficacy of facemasks by at least 99.0%, i.e. 100 times better and a peak performance of 1000 times, against avian influenza virus H5N1. Disposable facemasks are thus far not very...

Americans Say Maintain or Increase Funding for Global Health and Development, but Take Care of Problems at Home First in the Recession.
May 18, 2009... Two-thirds of the public supports maintaining (39%) or increasing (26%) U.S. government funding to improve health in developing countries, while fewer than a quarter (23%) say the government is spending too much on global health, according to a...

HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials.
May 18, 2009... The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH) (see also HIV/AIDS). This...

Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research.
May 18, 2009... Sangamo BioSciences, Inc. (NASDAQ:SGMO), the world leader in the research and development of zinc finger DNA-binding proteins (ZFPs), announced that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates...

Leading Vaccine Discovery Expert Joins the International AIDS Vaccine Initiative IAVI.
May 18, 2009... Dr. C. Richter (Rick) King, former Senior Vice President of Research at GenVec, Inc., has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Vaccine Discovery. In his new position, Dr. King will play a vital role in...

MRSA Activists Rally for World MRSA Day.
May 18, 2009... MRSA Survivors Network, the prominent advocacy group launches the inaugural World MRSA Day - Oct. 2nd and the official web site, www.worldmrsaday.org. MRSA activists call for world unity from governments, the healthcare industry and the...

Cancer-causing virus associated with higher risk of new HIV infection.
May 18, 2009... Infection with anal human papillomavirus (HPV), a virus that can cause anal and cervical cancers, is associated with a higher risk of new HIV infection in previously HIV-negative men who have sex with men (MSM), according to new UCSF research...